TOP TIERMARKET NEWSWIRE
News & sentiment

IMMUNITYBIO INC (IBRX) — News & AI sentiment

IMMUNITYBIO INC (IBRX) news roundup. 4 stories in the last 24 hours, 5 in the past week, 12 over 30 days. Average 24-hour sentiment is 59.5/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $3.9M — net selling of $3.9M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
4
avg sentiment 59.5/100
7d stories
5
avg sentiment 59.2/100
30d stories
12
avg sentiment 57.9/100
Insider net (90d)
$3.9M
0 buys · 5 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on IBRX

5h ago
5h ago
8h ago
24h ago
3d ago
Jul 20
Jul 17
Jul 16
Jul 14
Jul 10
ImmunityBio: A Long-Term Bull Case Worth Watching
Seeking Alpha63 · neutralanalyst
Jul 7
Jul 6
Jun 30
Jun 26
Jun 24
Jun 19
Jun 11
Jun 10
ImmunityBio, Inc. (IBRX) files 8-K
SEC 8-K50 · neutralgeneral
Jun 10
Jun 6
Jun 1
May 29
May 28
May 26
May 26
Open IBRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →